These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12205697)

  • 1. Assessing the gain in diagnostic performance when combining two diagnostic tests.
    Macaskill P; Walter SD; Irwig L; Franco EL
    Stat Med; 2002 Sep; 21(17):2527-46. PubMed ID: 12205697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verification bias-corrected estimators of the relative true and false positive rates of two binary screening tests.
    Alonzo TA
    Stat Med; 2005 Feb; 24(3):403-17. PubMed ID: 15543634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is the HPV test to supplement vaginal smears in menopausal women?].
    Gustavsson I; Gyllensten U; Lindell M; Wilander E
    Lakartidningen; 2010 Feb 24-Mar 2; 107(8):528-9. PubMed ID: 20384066
    [No Abstract]   [Full Text] [Related]  

  • 4. Some issues in resolution of diagnostic tests using an imperfect gold standard.
    Hawkins DM; Garrett JA; Stephenson B
    Stat Med; 2001 Jul; 20(13):1987-2001. PubMed ID: 11427955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies about diagnostic tests: interpreting the results].
    Salech F; Mery V; Larrondo F; Rada G
    Rev Med Chil; 2008 Sep; 136(9):1203-8. PubMed ID: 19030668
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnostic utility of multiple-level likelihood ratios.
    Bowden SC; Loring DW
    J Int Neuropsychol Soc; 2009 Sep; 15(5):769-76. PubMed ID: 19635177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The agreement chart as an alternative to the receiver-operating characteristic curve for diagnostic tests.
    Bangdiwala SI; Haedo AS; Natal ML; Villaveces A
    J Clin Epidemiol; 2008 Sep; 61(9):866-74. PubMed ID: 18687288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian estimation for performance measures of two diagnostic tests in the presence of verification bias.
    Aragon DC; Martinez EZ; Achcar JA
    J Biopharm Stat; 2010 Jul; 20(4):821-34. PubMed ID: 20496208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the likelihood ratios of two binary diagnostic tests in paired designs.
    Nofuentes JA; Del Castillo Jde D
    Stat Med; 2007 Sep; 26(22):4179-201. PubMed ID: 17357992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A non-inferiority test for diagnostic accuracy based on the paired partial areas under ROC curves.
    Li CR; Liao CT; Liu JP
    Stat Med; 2008 May; 27(10):1762-76. PubMed ID: 17968858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible.
    Alonzo TA; Kittelson JM
    Biometrics; 2006 Jun; 62(2):605-12. PubMed ID: 16918926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate statistical methods are required to assess diagnostic tests for replacement, add-on, and triage.
    Hayen A; Macaskill P; Irwig L; Bossuyt P
    J Clin Epidemiol; 2010 Aug; 63(8):883-91. PubMed ID: 20079607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting high-risk human papillomavirus in liquid-based cytology specimens.
    Qureshi MN
    Acta Cytol; 2005; 49(5):582. PubMed ID: 16334042
    [No Abstract]   [Full Text] [Related]  

  • 14. Pitfalls of internet-accessible diagnostic tests: inadequate performance of a CE-marked Chlamydia test for home use.
    Michel CE; Saison FG; Joshi H; Mahilum-Tapay LM; Lee HH
    Sex Transm Infect; 2009 Jun; 85(3):187-9. PubMed ID: 19398434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous comparison of sensitivity and specificity of two tests in the paired design: a straightforward graphical approach.
    Newcombe RG
    Stat Med; 2001 Mar; 20(6):907-15. PubMed ID: 11252012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV testing in liquid specimens.
    Geyer SJ
    Acta Cytol; 2006; 50(5):599-600. PubMed ID: 17017457
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
    J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into latent class analysis of diagnostic test performance.
    Pepe MS; Janes H
    Biostatistics; 2007 Apr; 8(2):474-84. PubMed ID: 17085745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The likelihood ratio. An improved measure for reporting and evaluating diagnostic test results.
    Radack KL; Rouan G; Hedges J
    Arch Pathol Lab Med; 1986 Aug; 110(8):689-93. PubMed ID: 3755325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.